| Literature DB >> 30338287 |
Linxiao Wu1, Adrián Magaz1, Tao Wang1,2, Chaozong Liu3, Arnold Darbyshire1, Marilena Loizidou1, Mark Emberton1, Martin Birchall4, Wenhui Song1.
Abstract
This article contains data related to the research article entitled "Stiffness memory of indirectly 3D-printed elastomer nanohybrid regulates chondrogenesis and osteogenesis of human mesenchymal stem cells" [1] (Wu et al., 2018). Cells respond to the local microenvironment in a context dependent fashion and a continuous challenge is to provide a living construct that can adapt to the viscoelasticity changes of surrounding tissues. Several materials are attractive candidates to be used in tissue engineering, but conventional manufactured scaffolds are primarily static models with well-defined and stable stiffness that lack the dynamic biological nature required to undergo changes in substrate elasticity decisive in several cellular processes key during tissue development and wound healing. A family of poly (urea-urethane) (PUU) elastomeric nanohybrid scaffolds (PUU-POSS) with thermoresponsive mechanical properties that soften by reverse self-assembling at body temperature had been developed through a 3D thermal induced phase transition process (3D-TIPS) at various thermal conditions: cryo-coagulation (CC), cryo-coagulation and heating (CC + H) and room temperature coagulation and heating (RTC + H). The stiffness relaxation and stiffness softening of these scaffolds suggest regulatory effects in proliferation and differentiation of human bone-marrow derived mesenchymal stem cells (hBM-MSCs) towards the chondrogenic and osteogenic lineages.Entities:
Year: 2018 PMID: 30338287 PMCID: PMC6186969 DOI: 10.1016/j.dib.2018.09.068
Source DB: PubMed Journal: Data Brief ISSN: 2352-3409
Fig. 1Schematics of hBM-MSCs culture, expansion, seeding and differentiation towards the chondrogenic and osteogenic lineages.
Physical, tensile and compression mechanical properties of 3D-TIPS PUU-POSS scaffolds with various infill densities.
| 80 | 44 ± 3 | 96.2 ± 0.3 | 0.54 ± 0.02 | 0.82 ± 0.03 | |
| 70 | 40 ± 3 | 96.5 ± 0.3 | 0.48 ± 0.01 | 0.75 ± 0.01 | |
| 60 | 37 ± 5 | 96.8 ± 0.4 | 0.34 ± 0.01 | 0.63 ± 0.02 | |
| 50 | 36 ± 4 | 96.9 ± 0.4 | 0.33 ± 0.03 | 0.48 ± 0.08 | |
| 40 | 30 ± 6 | 97.4 ± 0.5 | 0.17 ± 0.04 | 0.39 ± 0.03 | |
| 30 | 27 ± 3 | 97.7 ± 0.3 | 0.10 ± 0.02 | 0.25 ± 0.02 | |
| 80 | 56 ± 8 | 95.1 ± 0.7 | 0.38 ± 0.01 | 0.56 ± 0.01 | |
| 70 | 51 ± 4 | 95.5 ± 0.3 | 0.34 ± 0.04 | 0.41 ± 0.02 | |
| 60 | 49 ± 3 | 95.8 ± 0.3 | 0.26 ± 0.02 | 0.37 ± 0.03 | |
| 50 | 45 ± 5 | 96.1 ± 0.5 | 0.21 ± 0.01 | 0.27 ± 0.03 | |
| 40 | 41 ± 4 | 96.5 ± 0.3 | 0.11 ± 0.01 | 0.20 ± 0.02 | |
| 30 | 37 ± 2 | 96.8 ± 0.2 | 0.13 ± 0.01 | 0.12 ± 0.01 | |
| 80 | 48 ± 10 | 95.8 ± 0.8 | 0.35 ± 0.01 | 0.28 ± 0.01 | |
| 70 | 43 ± 4 | 96.2 ± 0.4 | 0.25 ± 0.02 | 0.26 ± 0.02 | |
| 60 | 39 ± 5 | 96.6 ± 0.4 | 0.22 ± 0.01 | 0.22 ± 0.01 | |
| 50 | 38 ± 3 | 96.7 ± 0.3 | 0.17 ± 0.02 | 0.15 ± 0.03 | |
| 40 | 33 ± 5 | 97.1 ± 0.4 | 0.12 ± 0.01 | 0.13 ± 0.01 | |
| 30 | 29 ± 3 | 97.5 ± 0.3 | 0.10 ± 0.01 | 0.10 ± 0.01 |
Physical and mechanical properties of 3D-TIPS PUU-POSS scaffolds (50% infill density) before and after incubation at body temperature (37°C) for 28 days.
| Day 0 | 36 ± 4 | 96.9 ± 0.4 | 0.98 ± 0.14 | 1.33 ± 0.09 | 179 ± 8 | 137 ± 22 | 0.33 ± 0.02 | 0.51 ± 0.08 | |
| Day 28 | 29 ± 4 | 97.4 ± 0.3 | 0.45 ± 0.08 | 0.77 ± 0.15 | 230 ± 13 | 115 ± 20 | 0.18 ± 0.03 | 0.16 ± 0.01 | |
| Day 0 | 45 ± 5 | 96.1 ± 0.5 | 0.53 ± 0.02 | 0.76 ± 0.05 | 236 ± 19 | 113 ± 27 | 0.22 ± 0.04 | 0.27 ± 0.03 | |
| Day 28 | 39 ± 5 | 96.7 ± 0.4 | 0.39 ± 0.09 | 0.72 ± 0.12 | 240 ± 18 | 110 ± 14 | 0.17 ± 0.02 | 0.13 ± 0.01 | |
| Day 0 | 38 ± 3 | 96.7 ± 0.3 | 0.44 ± 0.06 | 0.67 ± 0.03 | 146 ± 15 | 146 ± 12 | 0.17 ± 0.05 | 0.15 ± 0.01 | |
| Day 28 | 32 ± 3 | 97.2 ± 0.3 | 0.42 ± 0.08 | 0.65 ± 0.06 | 149 ± 19 | 146 ± 20 | 0.17 ± 0.02 | 0.12 ± 0.01 | |
Hysteresis values (i.e. energy loss) of the various scaffolds (50% infill density) during tensile and compression cyclic loading at day 0 and after incubation for 28 days at 37°C.
| 0–200 cycles | 160 ± 11 | 21 ± 8 | 15 ± 7 | ||
| 1000–1200 cycles | 133 ± 1 | 18 ± 2 | 13 ± 2 | ||
| 10,000–10,200 cycles | 24 ± 8 | 14 ± 3 | 13 ± 4 | ||
| 200,000–200,100 cycles | 15 ± 5 | 8 ± 3 | 11 ± 4 | ||
| 0–200 cycles | 31 ± 6 | 17 ± 4 | 12 ± 4 | ||
| 1000–1200 cycles | 17 ± 6 | 13 ± 5 | 10 ± 2 | ||
| 10,000–10,200 cycles | 12 ± 5 | 10 ± 4 | 9 ± 3 | ||
| 200,000–200,200 cycles | 10 ± 4 | 10 ± 4 | 9 ± 3 | ||
| 0–200 cycles | 274 ± 7 | 125 ± 10 | 12 ± 4 | ||
| 1000–1200 cycles | 124 ± 9 | 91 ± 10 | 14 ± 4 | ||
| 10,000–10,200 cycles | 101 ± 10 | 81 ± 4 | 13 ± 4 | ||
| 100,000–100,200 cycles | 90 ± 8 | 80 ± 4 | 12 ± 4 | ||
| 200,000–200,100 cycles | 60 ± 5 | 52 ± 3 | 10 ± 4 | ||
| 0–200 cycles | 63 ± 5 | 56 ± 8 | 8 ± 3 | ||
| 1000–1200 cycles | 43 ± 5 | 35 ± 9 | 10 ± 5 | ||
| 10,000–10,200 cycles | 31 ± 5 | 23 ± 7 | 10 ± 4 | ||
| 100,000–100,200 cycles | 13 ± 5 | 15 ± 4 | 8 ± 4 | ||
| 200,000–200,100 cycles | 10 ± 4 | 9 ± 4 | 8 ± 3 |
Fig. 2Porosity analysis of 50% infill density scaffolds. Mercury porosimeter measurements in terms of pore size and pore size distribution [2].
Pore size and pore size distribution of 50% infill density scaffolds [2].
| 456,882–1000 | 29.75 | 58.46 | 1.55 | 2.65 | |
| 1000–100 | 11.25 | 22.10 | 48.67 | 83.16 | |
| 100–3 | 9.89 | 19.44 | 8.30 | 14.19 | |
| 50.89 | 100 | 58.52 | 100 | ||
| 439,998–1000 | 31.31 | 75.75 | 1.47 | 6 | |
| 1000–100 | 6.57 | 15.89 | 18.82 | 76.84 | |
| 100–3 | 3.45 | 8.36 | 4.2 | 17.16 | |
| 41.33 | 100 | 24.49 | 100 | ||
| 387,810–1000 | 48.64 | 95.16 | 2.68 | 58.51 | |
| 1000–100 | 0 | 0 | 0 | 0 | |
| 100–3 | 2.47 | 4.84 | 1.9 | 41.49 | |
| 51.11 | 100 | 4.58 | 100 |
Fig. 3Chondrogenic differentiation on 50% infill density scaffolds. (A-I) Histological analysis of chondrogenic differentiation at week 4: in cross-section for (A, D, G) 50CC, (B, E, H) 50CC+H, and (C, F, I) 50RTC+H. Stained with Hematoxylin and Eosin (H&E), Alcian Blue (A-Blue) and Collagen II (COL2). (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article).
Fig. 5Osteogenic differentiation on 50% infill density scaffolds. (A-I) Histological analysis of osteogenic differentiation at week 4: in cross-section for (A, D, G) 50CC, (B, E, H) 50CC+H, and (C, F, I) 50RTC+H. Stained with H&E, Alizarin red and Collagen I (COL1). (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article).
Fig. 4SEM and EDX imaging of hBM-MSCs cultured on the various 50% infill density scaffolds under chondrogenic and osteogenic conditions: (A) after 28 days chondrogenesis on 50CC, 50CC+H and 50RTC+H scaffolds; (B) after 21 days osteogenesis on 50CC, 50CC+H and 50RTC+H scaffolds; (C) human femoral head cartilage control; (D) human femoral head bone control. Scale bar 100 μm.
EDX element analysis of scaffolds (50% infill density) after day 28 chondrogenesis. (weight %, wt%; atomic concentration%, at%)
| 65.64 | 79.76 | 69.5 | 83.55 | 68.73 | 80.01 | 70.51 | 83.55 | |
| 17.60 | 16.01 | 18.42 | 14.7 | 20.42 | 17.92 | 16.42 | 14.70 | |
| 2.37 | 1.50 | 0.66 | 0.41 | 1.74 | 1.06 | 0.66 | 0.41 | |
| 1.37 | 1.19 | 0.61 | 0.36 | 0.37 | 0.19 | 0.71 | 0.36 | |
| 0.67 | 0.31 | 0.36 | 0.12 | 0.67 | 0.18 | 0.26 | 0.12 | |
| 0.92 | 0.38 | 0.28 | 0.03 | 0.92 | 0.05 | 0.08 | 0.03 | |
| 11.43 | 0.84 | 8.36 | 0.83 | 11.43 | 0.58 | 11.35 | 0.83 | |
| 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | |
HFH-C, human femoral head cartilage.
EDX element analysis of the scaffolds (50% infill density) after 21 days osteogenesis. (weight, wt%; atomic concentration%, at%)
| 77.62 | 88.99 | 83.63 | 91.44 | 61.27 | 73.34 | 69.23 | 84.03 | |
| 8.21 | 7.06 | 7.11 | 5.86 | 22.67 | 21.12 | 15.55 | 14.17 | |
| 0.71 | 0.42 | 0.65 | 0.37 | 3.49 | 2.27 | 0.63 | 0.40 | |
| 1.43 | 0.70 | 0.24 | 0.11 | 2.38 | 1.86 | 0.33 | 0.17 | |
| 0.83 | 0.37 | 1.27 | 0.54 | 0.36 | 0.17 | 0.22 | 0.10 | |
| 3.72 | 1.93 | 2.66 | 0.88 | 1.48 | 0.61 | 0.29 | 0.11 | |
| 7.48 | 0.52 | 4.45 | 0.30 | 8.35 | 0.63 | 13.74 | 1.02 | |
| 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | |
HFH-B, human femoral head bone.
| Subject area | |
| More specific subject area | |
| Type of data | |
| How data was acquired | |
| Data format | |
| Experimental factors | |
| Experimental features | |
| Data source location | |
| Data accessibility |